Blue Cross Blue Shield · Mitraclip Secondary Mr · US health-plan appeal rights

Mitraclip Secondary Mr denied due to quantity / dose limits by Blue Cross Blue Shield?

Q: How long do I have to appeal a Blue Cross Blue Shield Mitraclip Secondary Mr denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Blue Cross Blue Shield typically requires

Blue Cross Blue Shield's specific coverage criteria for mitraclip secondary mr are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: BCBS — Transcatheter Mitral Valve Repair / Anthem clinical guideline TEER

The Blue Cross Blue Shield angle on Mitraclip Secondary Mr

## Why BCBS Denied MitraClip for Secondary Mitral Regurgitation Under Quantity Limits

A quantity-limit denial for MitraClip in secondary mitral regurgitation typically arises in one of two clinical scenarios: (1) a request for a repeat or redo TEER procedure after a prior MitraClip implantation, or (2) a request for implantation of additional clip devices beyond what BCBS's policy designates as the standard number per session. BCBS's medical policy may limit coverage to an initial procedure or to a defined number of clips, requiring additional justification when clinical circumstances call for more.

## Why This Denial Is Appealable

Quantity-limit policies are written for typical cases; your clinical situation may fall outside the assumed norm. If a redo procedure is needed because the initial repair was insufficient, or if your anatomy requires additional clips to achieve adequate leaflet coaptation, your cardiologist can document the specific clinical rationale that distinguishes your case from the policy's baseline assumption. The appeal should establish that the quantity requested is clinically necessary for this patient, not a general challenge to the policy itself.

## Federal Appeal Framework

Internal appeal: File within the plan's deadline (typically 180 days). Standard pre-service decisions within 15–30 days; urgent decisions within 72 hours.
External review (ACA §2719 / ERISA §503): Quantity-limit denials that involve medical judgment are eligible for independent external review within approximately four months of the final internal denial.
Expedited review: Available when delay poses health risk; typically resolved within 72 hours.

## Documentation to Gather

1. Procedural planning documentation: Your structural cardiologist's procedure plan, including the anticipated number of clips and the anatomical rationale for each, tied to echo findings. 2. Echo/imaging reports: Current imaging confirming leaflet anatomy, coaptation gap, and the structural basis for the planned approach. 3. Redo-procedure justification (if applicable): For a repeat procedure, documentation of the prior intervention, its outcome, residual or recurrent MR severity, and why repeat TEER is indicated rather than surgical intervention. 4. Heart team note: Multidisciplinary team agreement that the quantity requested is appropriate for your anatomy and clinical status. 5. Prescriber letter: A letter from your interventional cardiologist explaining why the specific quantity requested is the minimum necessary to achieve the clinical goal and how it falls within or is supported by the FDA-approved labeling.

## Criteria-Mapping Structure

Request BCBS's medical policy language specifying the quantity limit and the basis for exceptions. Map your case:

| Policy Limit | Clinical Justification for Exception | Supporting Document | |---|---|---| | Standard quantity per session | Anatomical complexity requiring additional clips | Echo + procedure plan | | Prior procedure limitation | Outcome of prior procedure + residual MR severity | Operative report + echo | | Guideline support for quantity | Structural cardiologist's rationale citing IFU parameters | Prescriber letter | | Heart team consensus | MDT agreement documented | Heart team note |

The goal is to show that your request is not a preference for more than necessary, but a clinical determination that the quantity is the minimum required to achieve the FDA-labeled therapeutic objective.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Blue Cross Blue Shield appeals

Other denial reasons for Blue Cross Blue Shield Mitraclip Secondary Mr

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.